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SnapShot: Spliceosome Dynamics II
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Numerous mechanisms exploit or modulate the conformational/compositional dynamics of spliceosomes to regulate splicing. The majority of higher eukaryotic protein-coding 
genes contain more than one intron and the derived pre-mRNAs can be alternatively spliced. Diverse principles ensure the reliable identification of authentic splice sites while 
concomitantly providing flexibility in splice site choice during alternative splicing. Some species contain a second type of minor (U12-type) spliceosome.
Various forms of alternative splicing and their combination with alternative transcription initiation sites and/or alternative 3′-cleavage/polyadenylation sites vastly increases 
the number of mature transcripts that can derive from a single protein-coding gene. Kinetic and/or physical coupling of the spliceosome with signal transduction, chromatin 
organization, and transcription are important mechanisms that regulate alternative splicing (Kornblihtt et al., 2013). During splicing, stepwise assembly is one principle by which 
spliceosomes on the one hand ensure the faithful recognition of splice sites and on the other hand become susceptible to regulatory inputs to implement alternative splicing 
(Wahl et al., 2009). During assembly of a spliceosome, all reactive sites on a pre-mRNA are recognized several times by different factors, thus increasing fidelity. Assembly is 
largely controlled by spliceosome-associated RNA helicases and a G protein (Snu114) that act as ribonucleoprotein (RNP) remodeling enzymes. Similar to kinetic proofreading on 
the ribosome, the “ideality” of an assembly intermediate may determine how fast a remodeling enzyme can act and drive the intermediate along the productive splicing pathway 
(Query and Konarska, 2006). Thus, mutually exclusive, alternative splicing scenarios may be “serviced” with different kinetics by the spliceosome. Several spliceosomal heli-
cases can alternatively channel sub-optimal, slow converting intermediates into discard pathways. In addition to ultimately disassembling the spliceosome, the Prp43 helicase 
and its NTR1/2 cofactors may act as general discard factors in these proofreading/fidelity mechanisms (Semlow and Staley, 2012). By competing with productive splicing, dis-
card mechanisms may also influence the balance of alternatively spliced products. The highly variable length and, in some instances, enormous size of higher eukaryotic introns, 
poses a major challenge to splice site recognition. As a consequence, in higher eukaryotes spliceosomes typically first assemble across exons (Robberson et al., 1990), which 
are rather short and homogeneous in size, and subsequently switch in various ways to a cross-intron configuration (Schneider et al., 2010). Initial identification of possible splice 
sites on a substrate commits a pre-mRNA to the splicing pathway, while it is only during subsequent cross-exon to cross-intron switching that particular splice sites are func-
tionally paired and the ultimate splicing pattern of a pre-mRNA is cemented. Thus, initial cross-exon assembly also offers unique possibilities for regulating splice site choice. 
Choices between alternative splice sites are in part determined by trans-acting factors, which can be regulated in a development-, tissue-, differentiation-, or external stimulus-
dependent manner (Kornblihtt et al., 2013). In particular, serine/arginine-rich proteins (SR proteins) and heterogeneous nuclear ribonucleoproteins (hnRNPs) typically promote 
or interfere with recruitment of the splicing machinery to particular splice sites, respectively. SR proteins and hnRNPs contain RNA-binding domains (typically one or several 
RNA recognition motifs [RRMs]), via which they bind to exonic/intronic splicing enhancer (ESE/ISE) sequences and exonic/intronic splicing silencer (ESS/ISS) sequences on 
pre-mRNAs, respectively (Zhu et al., 2001). SR proteins also contain an arginine-serine dipeptide-rich domain (RS domain), in which the serine residues can be reversibly phos-
phorylated by SR protein kinases (SRPKs), thus modulating the RNA and protein interaction potentials of these domains (Zhou and Fu, 2013). RS domains represent one example 
of intrinsically unstructured protein regions. Intrinsically unstructured proteins and protein regions are particularly abundant among splicing factors (Korneta and Bujnicki, 2012), 
suggesting that many more regulatory principles of the spliceosome rely on them. They might enable the bridging of long distances, the contraction of distal components by 
folding-upon-binding transitions, fast binding kinetics, tunable interaction strengths or regulation by post-translational modifications. An additional level of complexity exists in 
many plants, fungi, and animals, which contain a second type of (minor or U12-dependent) spliceosome (Turunen et al., 2013). Although the minor spliceosome is responsible for 
the excision of less than 0.5% of introns in humans, which are characterized by distinct consensus sequences around the splice and branch sites, it is an essential machinery 
whose dysfunction is associated with diseases (Turunen et al., 2013). In the minor spliceosome, U11, U12, U4atac, and U6atac snRNPs functionally replace the major spliceoso-
mal U1, U2, U4, and U6 snRNPs, respectively. U11 and U12 are composed of different snRNAs and proteins compared to U1 and U2, while U4atac and U6atac contain unique 
snRNAs but the same proteins as the corresponding U4 and U6 snRNPs. The U5 snRNP is part of both machineries. The minor spliceosome is thought to function according to 
similar principles as the major spliceosome, except that U11 and U12 snRNPs form a stable di-snRNP and assemble in one step.
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